Please assess the completion status of the following clinical trial:

Trial Title: Personalized Risk Estimator for Rheumatoid Arthritis Family Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* First degree blood relative (parent, sibling, or child) with diagnosis of RA~* Age between 18 and 70 years old~Exclusion Criteria:~* Non-English speaking~* Sign/symptoms of rheumatoid arthritis (assessed by screening questionnaire and study staff)~* Rheumatoid arthritis~* Systemic lupus erythematosus~* Juvenile Idiopathic Arthritis~* Psoriatic Arthritis~* Ankylosing Spondylitis~* Mixed Connective Tissue Disease~* Reactive Arthritis~* Adult-Onset Still's Disease~* Sjogren's Syndrome~* Dermatomyositis~* Polymyositis~* Polymyalgia Rheumatica~* ANCA-associated Vasculitis~* Giant Cell Arteritis~* Polyarteritis Nodosa~* Behcet's Disease~* Relapsing Polychondritis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- General Rheumatoid Arthritis Education (Type: ACTIVE_COMPARATOR): Arm 1 participants will receive general information about RA.
- PRE-RA (Type: EXPERIMENTAL): Arm 2 participants will receive personalized RA risk education by the PRE-RA risk tool.
- PRE-RA Plus (Type: EXPERIMENTAL): Arm 3 participants will receive personalized RA risk education by the PRE-RA risk tool and health educator.

Based on this trial design, predict the completion outcome and termination type (if applicable).